Literature DB >> 21949920

Ring-fencing a budget for cancer drugs: is it fair?

J Graham1, J Cassidy, D Hughes, M Duerden.   

Abstract

Ring-fencing is defined as protecting funds for use in a specific area. In the National Health Service in the UK, various methods to ring-fence cancer have been employed over the years; more recently the Cancer Drugs Fund in England has enabled cancer drugs that would not normally be considered cost-effective to be provided to patients. This has created variation in provision between England and the devolved countries. While some would argue that ring-fencing allows major advances to be made in the treatment of a particular condition, others would argue that it is intrinsically unfair. In this debate, Graham and Cassidy have written an article arguing the affirmative position and Hughes and Duerden were invited to respond directly to their arguments. As with all the RCPE's 'Current controversies', the authors have been asked to take a deliberately polarised position and so the views they express may be somewhat overstated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21949920     DOI: 10.4997/JRCPE.2011.310

Source DB:  PubMed          Journal:  J R Coll Physicians Edinb        ISSN: 1478-2715


  1 in total

1.  The New and Non-Transparent Cancer Drugs Fund.

Authors:  Eifiona M Wood; Dyfrig A Hughes
Journal:  Pharmacoeconomics       Date:  2020-01       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.